Practice Guideline
doi: 10.1016/j.jacc.2008.08.002.
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Collaborators
- PMID: 19017521
- DOI: 10.1016/j.jacc.2008.08.002
Item in Clipboard
Practice Guideline
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
J Am Coll Cardiol.
.
Free article
No abstract available
Comment in
-
Aspirin for prevention of myocardial infarction and stroke: is the right dose 81 or 160 mg/day?J Am Coll Cardiol. 2009 May 26;53(21):2010; author reply 2010. doi: 10.1016/j.jacc.2008.11.063. J Am Coll Cardiol. 2009. PMID: 19460618 No abstract available.
Similar articles
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.Circulation. 2008 Oct 28;118(18):1894-909. doi: 10.1161/CIRCULATIONAHA.108.191087. Epub 2008 Oct 3. Circulation. 2008. PMID: 18836135 No abstract available.
-
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.J Am Coll Cardiol. 2010 Dec 7;56(24):2051-66. doi: 10.1016/j.jacc.2010.09.010. J Am Coll Cardiol. 2010. PMID: 21126648 No abstract available.
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3. Am J Gastroenterol. 2008. PMID: 18853965 No abstract available.
-
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8. Circulation. 2010. PMID: 21060077 Review. No abstract available.
-
[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].Recenti Prog Med. 2009 May;100(5):277-8. Recenti Prog Med. 2009. PMID: 19772220 Italian. No abstract available.
Cited by
-
Gut microbiota and myocardial infarction: A bibliometric analysis from 2004 to 2023.Heliyon. 2024 Aug 30;10(17):e37139. doi: 10.1016/j.heliyon.2024.e37139. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39296144 Free PMC article.
-
Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.Indian Heart J. 2024 Jul-Aug;76(4):280-285. doi: 10.1016/j.ihj.2024.07.007. Epub 2024 Jul 14. Indian Heart J. 2024. PMID: 39009075 Free PMC article. Clinical Trial.
-
Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions.J Cardiovasc Dev Dis. 2023 Jun 20;10(6):264. doi: 10.3390/jcdd10060264. J Cardiovasc Dev Dis. 2023. PMID: 37367429 Free PMC article.
-
Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.Medicine (Baltimore). 2023 May 12;102(19):e33711. doi: 10.1097/MD.0000000000033711. Medicine (Baltimore). 2023. PMID: 37171333 Free PMC article.
-
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.Trials. 2023 Mar 21;24(1):209. doi: 10.1186/s13063-023-07236-w. Trials. 2023. PMID: 36945020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
